Evangelos Vassos

The paper recalculates CNV penetrance for intellectual disability, showing lower estimates due to methodological differences, and recommends phenotype-specific risk reporting.

This study uses electronic health records to analyze the neuropsychiatric phenotype of 22q11.2 deletion syndrome at scale, revealing high prevalence of neurodevelopmental and psychiatric disorders.

This study identifies genetic risk factors for panic attacks and disorder through genome-wide meta-analysis and links them to multiple body systems and neuronal functions.

UPDOG improves trans-ancestral polygenic score prediction by considering genetic architecture of both discovery and test cohorts, showing improvements in two-thirds of cases across four ancestries and six phenotypes.

This study investigates how genetic factors vary with different components of major depressive disorder using UK Biobank data, finding that symptom count and duration significantly affect heritability.

This study uses polygenic risk scores for major depression to examine the continuous nature of depressive symptoms across a large UK Biobank sample.

This study identifies DNA methylation changes in blood samples from psychosis patients, including treatment-resistant schizophrenia, and links them to biological age, smoking, and cellular composition.

The paper examines the independent and combined effects of schizophrenia polygenic risk score and heavy cannabis use on psychotic disorder risk using EUGEI data, finding both factors independently increase risk.

This study finds a genetic link between schizophrenia polygenic risk and psychotic symptoms, particularly delusions, in Alzheimer's disease through a meta-analysis of 11 cohort studies.

This study investigates the genetic and environmental links between major depressive disorder and traumatic experiences using UK Biobank data, finding shared genetic factors and distinct patterns in trauma-exposed individuals.

This study examines the association between schizophrenia polygenic risk scores and 420 behavioural traits in the UK Biobank, identifying potential causal pathways and highlighting the need for further research.

This study examines the relationship between cannabis use and symptom profiles in first episode psychosis patients and population controls, finding that cannabis use correlates with positive symptoms and negative symptoms in patients.